News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Alimera Sciences Cancels IPO



4/9/2009 7:46:45 AM

Private Equity Hub -- Alimera Sciences Inc., an Atlanta-based ophthalmic pharmaceutical company, has withdrawn registration for a $75 million IPO, due to “current public market conditions.” It had planned to trade on the Nasdaq, with Credit Suisse and Citi serving as co-lead underwriters.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES